{
    "body": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20301466", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22422768", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24370574", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23595086", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20807279", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22787013", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22589293", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16601229", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25480325", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23908839"
    ], 
    "ideal_answer": [
        "Mutations in five genes \u2013 ryanodine receptor 2 (RYR2), calsequestrin 2(CASQ2), triadic (TRDN), calmodulin 1 (CALM1) and potassium channel, inwardly rectifying subfamily J, member 2 (KCNJ2)  \u2013 have been found to be associated with CPVT"
    ], 
    "exact_answer": [
        [
            "ryanodine receptor 2", 
            "RYR2"
        ], 
        [
            "calsequestrin 2", 
            "CASQ2"
        ], 
        [
            "triadin", 
            "TRDN"
        ], 
        [
            "calmodulin 1", 
            "CALM1"
        ], 
        [
            "potassium channel, inwardly rectifying subfamily J, member 2", 
            "KCNJ2"
        ]
    ], 
    "type": "list", 
    "id": "54c225bcf693c3b16b000002", 
    "snippets": [
        {
            "offsetInBeginSection": 1703, 
            "offsetInEndSection": 1921, 
            "text": "Mutation in four genes \u2013 RYR2, CASQ2, TRDN, and CALM1 \u2013 is known to cause CPVT or related phenotypes of adrenergically induced life-threatening arrhythmias. The presence of other as-yet unidentified loci is postulated ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20301466", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 239, 
            "offsetInEndSection": 384, 
            "text": "some KCNJ2 mutation carriers lack the ATS triad and sometimes share the phenotype of catecholaminergic polymorphic ventricular tachycardia (CPVT)", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22589293", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 246, 
            "offsetInEndSection": 513, 
            "text": "In 50 Japanese probands from unrelated families who satisfied clinical criteria for CPVT, genetic testing was conducted in all exons on 3 CPVT-related genes: cardiac ryanodine receptor 2 (RYR2), calsequestrin 2 (CASQ2) and inward rectifier potassium channel 2 (KCNJ2)", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23595086", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 621, 
            "offsetInEndSection": 947, 
            "text": "point mutations in RYR2, the gene encoding for the cardiac isoform of the RyR (RyR2), are associated with catecholaminergic polymorphic ventricular tachycardia (CPVT), an arrhythmogenic syndrome characterized by the development of adrenergically-mediated ventricular tachycardia in individuals with an apparently normal heart.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25480325", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 464, 
            "offsetInEndSection": 528, 
            "text": "Recessive CPVT variants are due to mutations in the CASQ2 gene. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24370574", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 367, 
            "offsetInEndSection": 507, 
            "text": "Recent studies have shown that CPVT is caused by mutations in the cardiac ryanodine receptor type 2 (RyR2) or calsequestrin 2 (CASQ2) genes.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23908839", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 689, 
            "offsetInEndSection": 817, 
            "text": "We identified three mutations in triadin which cosegregated with the disease on a recessive mode of transmission in two families", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22422768", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 206, 
            "text": "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a familial arrhythmogenic disorder associated with mutations in the cardiac ryanodine receptor (RyR2) and cardiac calsequestrin (CASQ2) genes.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16601229", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 209, 
            "text": "BACKGROUND: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia syndrome associated with mutations in the cardiac ryanodine receptor gene (Ryr2) in the majority of patients.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22787013", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 238, 
            "text": "BACKGROUND: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a familial arrhythmic syndrome caused by mutations in genes encoding the calcium-regulation proteins cardiac ryanodine receptor (RyR2) or calsequestrin-2 (CASQ2).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20807279", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 212, 
            "text": "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmogenic disease so far related to mutations in the cardiac ryanodine receptor (RYR2) or the cardiac calsequestrin (CASQ2) genes.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22422768", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 196, 
            "text": "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia syndrome associated with mutations in the cardiac ryanodine receptor gene (Ryr2) in the majority of patients", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22787013", 
            "endSection": "abstract"
        }
    ]
}